ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist/Senior Scientist, High-Throughput Screening at Until - ApplyBlast

Scientist/Senior Scientist, High-Throughput Screening

Until

4 days ago

San Francisco, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Scientist/Senior Scientist, High-Throughput Screening role manages the day-to-day execution of a cryoprotectant screening program, focusing on improving workflows, increasing throughput, and identifying less-toxic formulations. The position involves integrating primary cells and iPSC-derived models into scalable screening processes, developing mechanism-of-action assays, and advancing the understanding of cryoprotectant effects on cell viability. This role combines hands-on experimental work with team coordination to deliver screening milestones supporting organ-scale reversible cryopreservation.

Responsibilities

Manage and improve cryoprotectant screening workflows and increase throughput
Design and execute functional and mechanism-of-action assays for toxicity characterization
Coordinate screening team activities and mentor members to deliver milestones

Skills

About Until

untillabs.com

Headquarters

San Francisco, California, United States

Company Size

11-50 employees

View Profile

Until is a biotechnology company building a "pause button" for biology by developing reversible cryopreservation technologies so transplantable organs (and ultimately whole bodies) can be preserved until a recipient is found. Their work focuses on translating cryobiology fundamentals into engineered workflows across five dimensions: perfusion, cryoprotectants, cooling, rewarming, and organ health assessment. Until has assembled a multidisciplinary team and raised $100M+ to advance scalable, clinically translatable cryopreservation solutions that help patients waiting for donor organs today.